CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement Colchicine Reduces Cardiovascular Events in Chronic Coronary Disease The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry Impact of Positive and Negative Lesion Site Remodeling on Clinical Outcomes : Insights From PROSPECT A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate From organic and inorganic phosphates to valvular and vascular calcifications

Original Research2021 Jan 13.

JOURNAL:Circulation. Article Link

Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial

GG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al. Keywords: PCSK9 inhibition; lipoprotein(a)

Full Text PDF